Epilepsy Clinical Trials in New York

Showing 21-40 of 76 trials

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

NCT04457687

The primary purpose of this study is to provide continued access of lorcaserin to participants with Dravet syndrome and other refractory epilepsies.

Epilepsies, MyoclonicDrug Resistant Epilepsy

Eisai Inc.

Birmingham, Alabama, United States • Los Angeles, California, United States • Aurora, Colorado, United States +19 more locations

ACTIVE_NOT_RECRUITINGNA< 1 mile

Memory Retrieval and Encoding Investigated by Neural Stimulation

NCT04286776

The purpose of this research is to understand biomarkers of human memory through correlational analyses and to use focal electrical stimulation as a causal manipulation to understand how biomarkers of memory relate to other brain states and behavioral measures.

Epilepsy Intractable

University of Pennsylvania800 participantsStarted Oct 2014

Aurora, Colorado, United States • Atlanta, Georgia, United States • Bethesda, Maryland, United States +8 more locations

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Memory Retrieval and Encoding Investigated by Neural Stimulation

Epilepsy Trials in Other Cities

Human Epilepsy Project 2: Resistant Focal Seizures Study

Genetics of Rolandic Epilepsy

Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy

Long-term Cardiac Monitoring in Epilepsy

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Staccato Alprazolam and Photoparoxysmal Response

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

Neuroimaging Biomarker for Seizures

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Other Conditions in New York